World's Best Scientists 2026 revealed!
Rossella Elisei

Rossella Elisei

D-Index & Metrics

Medicine

D-Index
97
Citations
41582
World Ranking
9156
National Ranking
316

Overview

Rossella Elisei is affiliated with the University of Pisa in Italy and has made significant contributions primarily in the field of Medicine, with a focus on Endocrinology, Diabetes and Metabolism, Surgery, Oncology, Genetics, and Radiology, Nuclear Medicine and Imaging.

Their work extensively covers topics related to thyroid cancer diagnosis and treatment as well as thyroid and parathyroid surgery. Additional research topics include BRCA gene mutations in cancer, neuroendocrine tumor research advances, thyroid disorders and treatments, head and neck anomalies, and cancer-related molecular pathways.

Their frequent co-authors include:

  • Antonio Matrone
  • Eleonora Molinaro
  • Alessandro Prete
  • Carla Gambale
  • Cristina Romei

Rossella Elisei has published widely in several journals. The most common publication venues are:

  • Endocrine Abstracts
  • L Endocrinologo
  • Thyroid
  • The Journal of Clinical Endocrinology & Metabolism
  • Journal of Endocrinological Investigation

Selected recent publications include:

  • "Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer," 2023, New England Journal of Medicine
  • "2022 European Thyroid Association Guidelines for the Management of Pediatric Thyroid Nodules and Differentiated Thyroid Carcinoma," 2022, European Thyroid Journal
  • "A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer," 2021, International Journal of Molecular Sciences
  • "A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer," 2021, Thyroid
  • "Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities," 2021, International Journal of Molecular Sciences

Best Publications

  • European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

    Furio Pacini;Martin Schlumberger;Henning Dralle;Rossella Elisei

  • Revised American thyroid association guidelines for the management of medullary thyroid carcinoma

    Samuel A Wells;Sylvia L Asa;Henning Dralle;Rossella Elisei

  • Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

    Martin Schlumberger;Makoto Tahara;Lori J. Wirth;Bruce Robinson

  • Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

    Samuel A. Wells;Bruce G. Robinson;Robert F. Gagel;Henning Dralle

  • Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

    Marcia S Brose;Christopher M Nutting;Barbara Jarzab;Rossella Elisei

  • Cabozantinib in Progressive Medullary Thyroid Cancer

    Rossella Elisei;Martin J. Schlumberger;Stefan P. Müller;Patrick Schöffski

  • Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

    Michael Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;David Viola

  • Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders

    Rossella Elisei;Valeria Bottici;Fabiana Luchetti;Giancarlo Di Coscio

  • BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

    Rossella Elisei;Clara Ugolini;David Viola;Cristiana Lupi

  • Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

    F Pacini;F Pacini;Pw Ladenson;M Schlumberger;A Driedger

  • Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer

    Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;Young Kee Shong

  • Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

    Rossella Elisei;Barbara Cosci;Cristina Romei;Valeria Bottici

  • Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma

    F Pacini;Eleonora Molinaro;Mg Castagna;Laura Agate

  • Association of BRAF V600E Mutation with Poor Clinicopathological Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma

    Cristiana Lupi;Riccardo Giannini;Clara Ugolini;Agnese Proietti

  • Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

    Eleonora Molinaro;Cristina Romei;Agnese Biagini;Elena Sabini

  • Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma

    F Pacini;M Fontanelli;L Fugazzola;Rossella Elisei

  • Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer

    Martin J. Schlumberger;Rossella Elisei;Lars Bastholt;Lori J. Wirth

  • RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.

    Rossella Elisei;Cristina Romei;Tatiana Vorontsova;Barbara Cosci

  • Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment

    F Pacini;M Capezzone;Rossella Elisei;C Ceccarelli

  • Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

    Furio Pacini;Francesco Lippi;Nunzio Formica;Rossella Elisei

Frequent Co-Authors

Aldo Pinchera
Aldo Pinchera University of Pisa
Fulvio Basolo
Fulvio Basolo University of Pisa
Furio Pacini
Furio Pacini University of Siena
Paolo Vitti
Paolo Vitti University of Pisa
Paolo Miccoli
Paolo Miccoli University of Pisa
Martin Schlumberger
Martin Schlumberger University of Paris-Saclay
Steven I. Sherman
Steven I. Sherman The University of Texas MD Anderson Cancer Center
Bruce G. Robinson
Bruce G. Robinson University of Sydney
Kari Hemminki
Kari Hemminki Charles University
Stefano Landi
Stefano Landi University of Pisa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a wide range of online degree options, especially if you have a background in nursing or are considering a transition into healthcare. Many students interested in advancing their roles or shifting into nursing are looking for flexible, affordable educational pathways.

For those aiming for leadership or research positions in healthcare, phd in nursing online programs offer a path to the highest levels of academic and clinical practice. If you're already an RN seeking greater career opportunities, the cheapest rn to bsn programs help you earn your bachelor's degree without breaking the bank.

For non-nurses with a bachelor’s degree in another field who want to become nurses quickly, direct entry msn programs for non nurses online provide a fast-track into advanced nursing roles. Similarly, if you are searching for accessible entry points into nursing, online adn programs for non nurses are available, often with less stringent admission requirements.

Each of these pathways can help diversify your career in healthcare, making it easier to balance education, work, and personal commitments.

Best Scientists Citing Rossella Elisei

Trending Scientists